Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Trademark Destroying Cancer at the Speed of Light
View:
Post by enriquesuave on Jun 28, 2021 6:52pm

Trademark Destroying Cancer at the Speed of Light

Comment by Johnandrose22 on Jun 28, 2021 7:04pm
The company is sending a message here...and a good one.
Comment by Pandora on Jun 28, 2021 7:16pm
Two new trademark applications -- what do you rationalize as being the going forward strategy?
Comment by Johnandrose22 on Jun 28, 2021 7:21pm
Pandora....To be honest....no clue.
Comment by Johnandrose22 on Jun 28, 2021 7:38pm
Pandora...apologies for a rather flippant response...If anything I am pleased that the trademark application bespeaks the company’s ongoing confidence in what it possesses...I pray that their strategy going forward will be timely and effective. Best to you. John
Comment by Pandora on Jun 29, 2021 11:36pm
No problem John, I have been around these boards long enough that everything just rolls off. Besides I did not recognize it as flippant -- I thought it was just you saying you had no clue! :-)) I'll try to keep a closer eye on flippant.
Comment by Yajne on Jun 28, 2021 8:40pm
Interesting that these trademark applications files immediately prior to the AGM. Expect we'll see these embedded in the AGM corporate deck in some fashion. Hopefully they'll soon share some additional&promising patient data as well.
Comment by StevenBirch on Jun 28, 2021 9:13pm
I also took Enriquesuave's investigative reporting as a positive. I still expect the quarterly report sometime in the second half of July but we should get something at or before the AGM.
Comment by fredgoodwinson on Jun 29, 2021 5:00am
Also taking this trademark as a positive. In securing ’Destroying cancer at the speed of light’  as their logo (and an excellent one) and since likely confined to the use of TLD1433/Rutherrin atm the logical conclusion is that Rutherrin is destroying cancer at the speed of light - and this is actually something that they’ve been telling us in a succession of Quarterlies.   If they ...more  
Comment by Johnandrose22 on Jun 29, 2021 7:39am
Upon further reflection (after a first cup of morning coffee) I am finding the company’s descriptive words to define itself remarkably powerful: ”Destroying Cancer”...not minimizing, reducing or managing but actual and definitive destruction ”At The Speed Of Light”....instantly ”One Patient At A Time”...individual and personalized treatment and therapy. Impressive claims, indeed! John
Comment by CancerSlayer on Jun 29, 2021 12:13pm
  Interesting "timing" for sure...quote has been around a while & just now they file for a trademark?  Something just tipped the balance....perhaps strong(er) data.  Such a company/treatment identifier speaks volumes about their confidence in this form of ACT moving forward.  Thanks for that tidbit enrique...  
Comment by enriquesuave on Jun 29, 2021 12:26pm
I agree with your thoughts their slayer. Confidence is the word. 
Comment by menoalittle on Jun 29, 2021 1:17pm
>>  Interesting "timing" for sure...quote has been around a while & just now they file >> for a trademark?  Something just tipped the balance....perhaps strong(er) data. Ah...  okay.  That got my attention, and now it makes sense. Thanks, guys.
Comment by Oilminerdeluxe on Jun 29, 2021 3:03pm
Or.... they don't have much else going on and saved that to get a slightly happier crowd at the agm. But let's hope it won't be a boring event.
Comment by StevenBirch on Jun 29, 2021 4:29pm
That seems a little cynical Oilminer, I think they proved 2 years ago with the financing that they don't care about going into the AGM with window dressing to keep it upbeat. I think they are about plodding ahead, doing what they have to do and personally I like that.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250